Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

about

Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)Pleiotropic Effects of Metformin on Cancer

P2860

Q58742476-F3A4E5DB-1CC1-49D6-B08B-31D7332A95B1 Q59138314-DB5542AA-F107-42EC-A16E-94B49814C4DF

P2860

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

Item

http://www.wikidata.org/entity/Q52331264

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@en

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@nl

type

Item

label

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@en

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@nl

prefLabel

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@en

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@nl

P1476

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

@en

P2093

Guiju Tang

http://www.w3.org/2001/XMLSchema#string

Jianfeng Guo

http://www.w3.org/2001/XMLSchema#string

Jing Cai

http://www.w3.org/2001/XMLSchema#string

Lili Yu

http://www.w3.org/2001/XMLSchema#string

Ting Liu

http://www.w3.org/2001/XMLSchema#string

Yapei Zhu

http://www.w3.org/2001/XMLSchema#string

Zaiju Huang

http://www.w3.org/2001/XMLSchema#string

Zehua Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies

Metformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer Patients

Cancer statistics, 2016

Epigenetic modifications and human disease

EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo.

P304

1899-1911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2018.4343

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29620187

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

metformin

P932

5919713

http://www.w3.org/2001/XMLSchema#string

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

about

P2860

P2860

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932